Brief Summary

No evidence-based, evaluated, population-appropriate resources exist to translate Type 2 diabetes (T2DM) primary prevention messages to Canadians. Significant barriers to such large-scale interventions include:

  • the need to identify, then target specific at-risk populations
  • significant time-delays before any program effects on T2DM incidence may manifest. However, women with gestational diabetes (GDM) are a readily identifiable study cohort at significant risk for recurrent GDM and T2DM-hence GDM women provide important opportunities for rigorous, timely diabetes prevention intervention studies. The investigators propose FDD (Families Defeating Diabetes), a Canadian diabetes prevention intervention uniquely targeting women with recent GDM in the context of their families. FDD is a 12 month, randomized, controlled T2DM prevention intervention targeting women with recent GDM, within their family context. Five Canadian sites and 177 women will participate. Multifaceted information and behavioural change support will be provided for diet, weight loss, and activity through: seminar, walking groups, electronic updates, password-protected social networking site. Subjects and controls will be compared for: DM prevention knowledge; diet/activity choices; HbA1C; body habitus at study onset/during study/12 months/24 months. Consenting immediate family members will have protective knowledge/diet/exercise choices/body habitus measures documented at study onset/12 and 24 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 27, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 30, 2011

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

September 12, 2017

Status Verified

September 1, 2017

Enrollment Period

5.2 years

First QC Date

August 27, 2011

Last Update Submit

September 11, 2017

Conditions

Keywords

gestational diabetesGDMprevention

Outcome Measures

Primary Outcomes (1)

  • Proportion of study subjects achieving a 7% weight loss

    Weight loss in intervnetional vs control women will be documented by one year post-partum

    one year post-partum

Study Arms (2)

Lifestyle and behavioural change support

ACTIVE COMPARATOR

Interventional arm will be offered a 12 month lifestyle program translating DM prevention issues to the family milieu

Other: FDD program

control

NO INTERVENTION

Control arm will receive standard diabetes prevention care as outlined in the current Canadian diabetes association Clinical Practice Guidelines.

Interventions

FDD is a 12 month lifestyle intervention and behavioural support program delivered in the context of the surrounding family

Lifestyle and behavioural change support

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • women aged 18-50 with recent GDM
  • able to speak and write English
  • overweight (BMI \>25 before pregnancy)
  • significant other family members

You may not qualify if:

  • women with Types 1 or 2 diabetes
  • women with BMI under 25

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Josephs Health Care

London, Ontario, N6A 4V2, Canada

Location

MeSH Terms

Conditions

Diabetes, Gestational

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, FRCPC, Cert Endo, Professor of Medicine, UWO

Study Record Dates

First Submitted

August 27, 2011

First Posted

August 30, 2011

Study Start

January 1, 2012

Primary Completion

March 1, 2017

Study Completion

March 1, 2017

Last Updated

September 12, 2017

Record last verified: 2017-09

Locations